mTOR is frequently activated in diverse carcinomas and also widely accepted as a master regulator for cell proliferation control (Bar-Peled and Sabatini, 2014; Ben-Sahra and Manning, 2017; Mossmann et al, 2018). Here, MTOR is linked to carcinoma.